Atlas Trials

Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer

Clinical trial NCT03738228 · COMPLETED

Trial details

NCT number
NCT03738228
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell CarcinomaStage IB2 Cervical Cancer AJCC v8Stage II Cervical Cancer AJCC v8Stage IIA Cervical Cancer AJCC v8Stage IIA1 Cervical Cancer AJCC v8Stage IIA2 Cervical Cancer AJCC v8Stage IIB Cervical Cancer AJCC v8Stage IIIB Cervical Cancer AJCC v8Stage IVA Cervical Cancer AJCC v8
Start date
2019-01-07
Primary completion
2022-05-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.